Dr. Michael Benatar is a Professor of Neurology and Walter Bradley Chair in ALS Research at the University of Miami. He is Executive Director of the University of Miami ALS Center and also serves as Chief of the Neuromuscular Division, and Vice Chair of Clinical & Translational Research in the Department of Neurology. He obtained his medical degree at the University of Cape Town in South Africa and is also trained in both basic neuroscience (DPhil, Oxford) and clinical research methods (Masters in the Science of Clinical Research Emory). He leads an active clinical and translational research program focused on biomarker and therapy development for ALS and Myasthenia Gravis. He is the principal investigator of the ongoing Pre-Symptomatic Familial ALS (Pre-fALS) study as well as the CReATe Consortium, a rare diseases clinical research consortium focused on ALS and related neurodegenerative diseases.